Are you over 18 and want to see adult content?
More Annotations
![JAZZKALENDERN – Jazzkalendern – Mer jazz för folket](https://www.archivebay.com/archive/9820afd3-8aeb-48bf-acd6-ec60d954d610.png)
JAZZKALENDERN – Jazzkalendern – Mer jazz för folket
Are you over 18 and want to see adult content?
![Offres d'emploi, emplois | Jobingenieur](https://www.archivebay.com/archive/a1544b6a-cc0d-4c22-a993-6f477710a7c7.png)
Offres d'emploi, emplois | Jobingenieur
Are you over 18 and want to see adult content?
![Two Great Parks For The Price of One | Amusement Park in PA | Dorney Park](https://www.archivebay.com/archive/031e347c-94b0-4025-a5c2-7689c49bc135.png)
Two Great Parks For The Price of One | Amusement Park in PA | Dorney Park
Are you over 18 and want to see adult content?
![Kroger REWARDS World Mastercard® | Home 1-2-3 REWARDS Credit Card](https://www.archivebay.com/archive/a0a5524c-4826-4db8-a9eb-ca9733657385.png)
Kroger REWARDS World Mastercard® | Home 1-2-3 REWARDS Credit Card
Are you over 18 and want to see adult content?
![Janssen márkakozmetika Kispesten, dr. Derm gépek.](https://www.archivebay.com/archive/8a55a4c4-23d3-49ba-a548-e3f3a9873187.png)
Janssen márkakozmetika Kispesten, dr. Derm gépek.
Are you over 18 and want to see adult content?
Favourite Annotations
![A complete backup of vriendenopdefiets.nl](https://www.archivebay.com/archive/d5f9570d-601f-4f40-8390-79a64f36610d.png)
A complete backup of vriendenopdefiets.nl
Are you over 18 and want to see adult content?
![A complete backup of avukatbarosu.com](https://www.archivebay.com/archive/4dc05d1c-7297-4eba-a4f0-3ceced63d5b1.png)
A complete backup of avukatbarosu.com
Are you over 18 and want to see adult content?
![A complete backup of porschedealer.com](https://www.archivebay.com/archive/44d7f829-ca5d-40d3-8485-3cbcff920ab3.png)
A complete backup of porschedealer.com
Are you over 18 and want to see adult content?
![A complete backup of planeaciondocentecbtis21.blogspot.com](https://www.archivebay.com/archive/3e44270f-f891-46c7-930f-5da73a48b443.png)
A complete backup of planeaciondocentecbtis21.blogspot.com
Are you over 18 and want to see adult content?
![A complete backup of inquiringchef.com](https://www.archivebay.com/archive/8bc7958b-f754-4ad8-aef9-63a84e9a563c.png)
A complete backup of inquiringchef.com
Are you over 18 and want to see adult content?
![A complete backup of sqarra.wordpress.com](https://www.archivebay.com/archive/681624aa-edb2-4483-a193-183719416f79.png)
A complete backup of sqarra.wordpress.com
Are you over 18 and want to see adult content?
Text
their food intake.
CHANGES IN TOTAL SPERM COUNT AFTER GASTRIC BYPASS AND Forty-six adult men who underwent gastric bypass (n = 20) or sleeve gastrectomy (n = 26) were included. Total sperm count tended to be lower at 6 months and showed a significant decrease at 12 months in both surgery groups, at −69.5 million (−96.8 to −42.2 million; P = 0.0021). Total sperm count at 12 months relative to baseline was −41.4 million (P = .0391) after gastric bypass and COMPARISON OF ENDOSTAPLER PERFORMANCE IN CHALLENGING test and a Kruskal-Wallis ranked median test with a ¼ .05 to compare the medians were conducted. H 0: The population medians are all equal. H 1: The medians are not all equal. Malformed staples evaluation. Thenumber of malformed
HEALTH DISPARITY IN ACCESS TO BARIATRIC SURGERY treatment and, therefore, subsequent worse postoperative outcomes, including longer hospital lengths of stay and increased mortality . Sociodemographicdisparities intermsofaccesstobariat- “WHY WON'T MY PATIENTS DO WHAT'S GOOD FOR THEM Keynote address “Why won’t my patients do what’s good for them?” Motivational interviewing and treatment adherence Allan Zuckoff, Ph.D.* Department of THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AFTER The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is discouraged after bariatric surgery. The effect of NSAIDs on patients who have undergone sleeve gastrectomy (SG) is not well studied. Moreover, the rate of NSAID use after SG is unknown. LAPAROSCOPIC DISTALIZATION OF GASTRIC BYPASS Background: The patient is a 37 year-old female with a history of super morbid obesity who had previously undergone a laparoscopic roux-en-Y gastric bypass 5 years ago with a 120cm roux limb. She initially experienced satisfactory weight loss, however subsequently had significant weight re-gain despite compliance with dietary advice and continued exercise. DEHYDRATION: A CAUSE FOR CONCERN Dehydration occurs when the body loses too much fluid. Signs and symptoms of dehydration include: thirst, decrease in skin turgor, dry or cool skin, dry mucous membranes, constipation, low or minimal urine output, muscle cramps, tachycardia, hypotension, light headedness, feeling dizzy, headache, fever , nausea, malaise, diaphoresis INTERPRETATION OF LABORATORY RESULTS AFTER GASTRIC BYPASS Results of 4835 patients were analyzed. Five-year follow-up was 58%. Blood levels of ferritin, mean-corpuscular-volume, thrombocytes, vitamin D, parathyroid-hormone, glycated hemoglobin (HbA1C), triglyceride, total-cholesterol, C-reactive-protein, gamma-glutamyl-transferase, alkaline-phosphatase, creatinine, vitamin B1, and total protein were related with weight loss response. BARIATRIC AND METABOLIC SURGERY IN PATIENTS WITH MORBID Weight loss at 2 years after surgery was similar for patients with MS and controls (total weight loss 31.6 ± 9.1 versus 31.8 ± 9.2, P = .735). No significant differences were seen in either the overall postoperative complication rate (7.9% versus 7.2%, P = .778), or serious postoperative complications (3.7% versus 2.8%, P = .430). All aspects of health-related quality of life (HRQoL EFFECT OF GASTRIC BYPASS ON GASTRIC SECRETION Subtotal gastrectomy was abandoned for the treatment of acid peptic disease because patients had difficulty in maintaining their body weight; the operation produced an intake deficiency. Gastric bypass is a reversible operation patterned after subtotal gastric resection and designed to produce weight loss in grossly obese people by restrictingtheir food intake.
CHANGES IN TOTAL SPERM COUNT AFTER GASTRIC BYPASS AND Forty-six adult men who underwent gastric bypass (n = 20) or sleeve gastrectomy (n = 26) were included. Total sperm count tended to be lower at 6 months and showed a significant decrease at 12 months in both surgery groups, at −69.5 million (−96.8 to −42.2 million; P = 0.0021). Total sperm count at 12 months relative to baseline was −41.4 million (P = .0391) after gastric bypass and COMPARISON OF ENDOSTAPLER PERFORMANCE IN CHALLENGING test and a Kruskal-Wallis ranked median test with a ¼ .05 to compare the medians were conducted. H 0: The population medians are all equal. H 1: The medians are not all equal. Malformed staples evaluation. Thenumber of malformed
HEALTH DISPARITY IN ACCESS TO BARIATRIC SURGERY treatment and, therefore, subsequent worse postoperative outcomes, including longer hospital lengths of stay and increased mortality . Sociodemographicdisparities intermsofaccesstobariat- “WHY WON'T MY PATIENTS DO WHAT'S GOOD FOR THEM Keynote address “Why won’t my patients do what’s good for them?” Motivational interviewing and treatment adherence Allan Zuckoff, Ph.D.* Department of GUIDELINES FOR GASTROSTOMY TUBE PLACEMENT AND ENTERAL Postbariatric hypoglycemia (PBH) affects up to 38% of Roux-en-Y gastric bypass (RYGB) patients. Severe cases are refractory to diet and medications. Surgical treatments including bypass reversal and pancreatectomy are highly morbid and hypoglycemia often recurs. We have developed a highly effective method of treatment by which enteral nutrition administered through a gastrostomy (G) tube INTERPRETATION OF LABORATORY RESULTS AFTER GASTRIC BYPASS Results of 4835 patients were analyzed. Five-year follow-up was 58%. Blood levels of ferritin, mean-corpuscular-volume, thrombocytes, vitamin D, parathyroid-hormone, glycated hemoglobin (HbA1C), triglyceride, total-cholesterol, C-reactive-protein, gamma-glutamyl-transferase, alkaline-phosphatase, creatinine, vitamin B1, and total protein were related with weight loss response. COMMENT ON: BARIATRIC SURGERY IN PATIENTS WITH PREVIOUS We have read with great interest this interesting and timely paper1. Although we share authors’ conclusions, 4 weeks interval between the infection and bariatric surgery is probably not safe. Hereby we report 2 cases of unexpected and asymptomatic pulmonary abnormalities discovered during the preoperative assessment of patients with recent infection of Sars-Cov-2. CHANGES IN TOTAL SPERM COUNT AFTER GASTRIC BYPASS AND Forty-six adult men who underwent gastric bypass (n = 20) or sleeve gastrectomy (n = 26) were included. Total sperm count tended to be lower at 6 months and showed a significant decrease at 12 months in both surgery groups, at −69.5 million (−96.8 to −42.2 million; P = 0.0021). Total sperm count at 12 months relative to baseline was −41.4 million (P = .0391) after gastric bypass and 15+ YEAR WEIGHT CHANGE OUTCOMES AND COMPLICATIONS AFTER Roux-en-Y gastric bypass (RYGB) is the most commonly performed bariatric surgery procedure in the United States. The short-term outcomes following RYGB have been well studied; however, evidence on long-term (≥5 years) outcomes following RYGB is sparse, particularly in the U.S. population. Using data from patients who underwent RYGB at Washington University School of Medicine in St. Louis, we ABNORMAL GLUCOSE TOLERANCE TESTING AFTER GASTRIC BYPASS the 1-way analysis of variance test, it was determined that no significant difference was present between the groups with respect to weight regain (P.631) or the %EBL (P.161; Table 4). MESENTERIC VISCERAL LIPECTOMY USING TISSUE LIQUEFACTION Visceral obesity is associated with diabetogenic and atherogenic abnormalities, including insulin resistance and increased risk for cardiometabolic diseases and mortality. Rodent lipectomy studies have demonstrated a causal link between visceral fat and insulin resistance, yet human omentectomy studies have failed to replicate this metabolic benefit, perhaps owing to the inability to HEALTH DISPARITY IN ACCESS TO BARIATRIC SURGERY treatment and, therefore, subsequent worse postoperative outcomes, including longer hospital lengths of stay and increased mortality . Sociodemographicdisparities intermsofaccesstobariat- ASSOCIATION BETWEEN OBESITY AND LOWER URINARY TRACT After matching propensity score forage, 73 male patients and 176 female patients were included in our study. In men, all IPSS items except “frequency” were significantly different between obese patients and controls; median scores were higher in the obese group. “WHY WON'T MY PATIENTS DO WHAT'S GOOD FOR THEM Keynote address “Why won’t my patients do what’s good for them?” Motivational interviewing and treatment adherence Allan Zuckoff, Ph.D.* Department of Psychology, University of Pittsburgh, Pittsburgh, Pennsylvania GUIDELINES FOR GASTROSTOMY TUBE PLACEMENT AND ENTERAL Postbariatric hypoglycemia (PBH) affects up to 38% of Roux-en-Y gastric bypass (RYGB) patients. Severe cases are refractory to diet and medications. Surgical treatments including bypass reversal and pancreatectomy are highly morbid and hypoglycemia often recurs. We have developed a highly effective method of treatment by which enteral nutrition administered through a gastrostomy (G) tube THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AFTER The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is discouraged after bariatric surgery. The effect of NSAIDs on patients who have undergone sleeve gastrectomy (SG) is not well studied. Moreover, the rate of NSAID use after SG is unknown. DEHYDRATION: A CAUSE FOR CONCERN Dehydration occurs when the body loses too much fluid. Signs and symptoms of dehydration include: thirst, decrease in skin turgor, dry or cool skin, dry mucous membranes, constipation, low or minimal urine output, muscle cramps, tachycardia, hypotension, light headedness, feeling dizzy, headache, fever , nausea, malaise, diaphoresis LAPAROSCOPIC DISTALIZATION OF GASTRIC BYPASS Background: The patient is a 37 year-old female with a history of super morbid obesity who had previously undergone a laparoscopic roux-en-Y gastric bypass 5 years ago with a 120cm roux limb. She initially experienced satisfactory weight loss, however subsequently had significant weight re-gain despite compliance with dietary advice and continued exercise. HEALTH DISPARITY IN ACCESS TO BARIATRIC SURGERY treatment and, therefore, subsequent worse postoperative outcomes, including longer hospital lengths of stay and increased mortality . Sociodemographicdisparities intermsofaccesstobariat- 15+ YEAR WEIGHT CHANGE OUTCOMES AND COMPLICATIONS AFTER Roux-en-Y gastric bypass (RYGB) is the most commonly performed bariatric surgery procedure in the United States. The short-term outcomes following RYGB have been well studied; however, evidence on long-term (≥5 years) outcomes following RYGB is sparse, particularly in the U.S. population. Using data from patients who underwent RYGB at Washington University School of Medicine in St. Louis, we COMPARISON OF ENDOSTAPLER PERFORMANCE IN CHALLENGING test and a Kruskal-Wallis ranked median test with a ¼ .05 to compare the medians were conducted. H 0: The population medians are all equal. H 1: The medians are not all equal. Malformed staples evaluation. Thenumber of malformed
MESENTERIC VISCERAL LIPECTOMY USING TISSUE LIQUEFACTION Visceral obesity is associated with diabetogenic and atherogenic abnormalities, including insulin resistance and increased risk for cardiometabolic diseases and mortality. Rodent lipectomy studies have demonstrated a causal link between visceral fat and insulin resistance, yet human omentectomy studies have failed to replicate this metabolic benefit, perhaps owing to the inability to EMPLOYING ENHANCED RECOVERY GOALS IN BARIATRIC SURGERY Original article Employing Enhanced Recovery Goals in Bariatric Surgery (ENERGY): a national quality improvement project using the Metabolic and Bariatric Surgery Accreditation and Quality “WHY WON'T MY PATIENTS DO WHAT'S GOOD FOR THEM Keynote address “Why won’t my patients do what’s good for them?” Motivational interviewing and treatment adherence Allan Zuckoff, Ph.D.* Department of GUIDELINES FOR GASTROSTOMY TUBE PLACEMENT AND ENTERAL Postbariatric hypoglycemia (PBH) affects up to 38% of Roux-en-Y gastric bypass (RYGB) patients. Severe cases are refractory to diet and medications. Surgical treatments including bypass reversal and pancreatectomy are highly morbid and hypoglycemia often recurs. We have developed a highly effective method of treatment by which enteral nutrition administered through a gastrostomy (G) tube THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AFTER The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is discouraged after bariatric surgery. The effect of NSAIDs on patients who have undergone sleeve gastrectomy (SG) is not well studied. Moreover, the rate of NSAID use after SG is unknown. DEHYDRATION: A CAUSE FOR CONCERN Dehydration occurs when the body loses too much fluid. Signs and symptoms of dehydration include: thirst, decrease in skin turgor, dry or cool skin, dry mucous membranes, constipation, low or minimal urine output, muscle cramps, tachycardia, hypotension, light headedness, feeling dizzy, headache, fever , nausea, malaise, diaphoresis LAPAROSCOPIC DISTALIZATION OF GASTRIC BYPASS Background: The patient is a 37 year-old female with a history of super morbid obesity who had previously undergone a laparoscopic roux-en-Y gastric bypass 5 years ago with a 120cm roux limb. She initially experienced satisfactory weight loss, however subsequently had significant weight re-gain despite compliance with dietary advice and continued exercise. HEALTH DISPARITY IN ACCESS TO BARIATRIC SURGERY treatment and, therefore, subsequent worse postoperative outcomes, including longer hospital lengths of stay and increased mortality . Sociodemographicdisparities intermsofaccesstobariat- 15+ YEAR WEIGHT CHANGE OUTCOMES AND COMPLICATIONS AFTER Roux-en-Y gastric bypass (RYGB) is the most commonly performed bariatric surgery procedure in the United States. The short-term outcomes following RYGB have been well studied; however, evidence on long-term (≥5 years) outcomes following RYGB is sparse, particularly in the U.S. population. Using data from patients who underwent RYGB at Washington University School of Medicine in St. Louis, we COMPARISON OF ENDOSTAPLER PERFORMANCE IN CHALLENGING test and a Kruskal-Wallis ranked median test with a ¼ .05 to compare the medians were conducted. H 0: The population medians are all equal. H 1: The medians are not all equal. Malformed staples evaluation. Thenumber of malformed
MESENTERIC VISCERAL LIPECTOMY USING TISSUE LIQUEFACTION Visceral obesity is associated with diabetogenic and atherogenic abnormalities, including insulin resistance and increased risk for cardiometabolic diseases and mortality. Rodent lipectomy studies have demonstrated a causal link between visceral fat and insulin resistance, yet human omentectomy studies have failed to replicate this metabolic benefit, perhaps owing to the inability to EMPLOYING ENHANCED RECOVERY GOALS IN BARIATRIC SURGERY Original article Employing Enhanced Recovery Goals in Bariatric Surgery (ENERGY): a national quality improvement project using the Metabolic and Bariatric Surgery Accreditation and Quality “WHY WON'T MY PATIENTS DO WHAT'S GOOD FOR THEM Keynote address “Why won’t my patients do what’s good for them?” Motivational interviewing and treatment adherence Allan Zuckoff, Ph.D.* Department of GUIDELINES FOR GASTROSTOMY TUBE PLACEMENT AND ENTERAL Postbariatric hypoglycemia (PBH) affects up to 38% of Roux-en-Y gastric bypass (RYGB) patients. Severe cases are refractory to diet and medications. Surgical treatments including bypass reversal and pancreatectomy are highly morbid and hypoglycemia often recurs. We have developed a highly effective method of treatment by which enteral nutrition administered through a gastrostomy (G) tube HEALTH IS A STATE OF COMPLETE PHYSICAL, MENTAL AND SOCIAL Health is a state of complete physical, mental, and social well-being and not merely the absence of disease or infirmity . As stated by the World Health Organization in 1948, health describes more than the mere integrity of the physical body. It depicts the wholesomeness of a human being understood as a composition of bodily, emotional, intellectual, and social as well as material parts, in INTERPRETATION OF LABORATORY RESULTS AFTER GASTRIC BYPASS Results of 4835 patients were analyzed. Five-year follow-up was 58%. Blood levels of ferritin, mean-corpuscular-volume, thrombocytes, vitamin D, parathyroid-hormone, glycated hemoglobin (HbA1C), triglyceride, total-cholesterol, C-reactive-protein, gamma-glutamyl-transferase, alkaline-phosphatase, creatinine, vitamin B1, and total protein were related with weight loss response. SLEEVE GASTRECTOMY AND GASTROESOPHAGEAL REFLUX: A The impact of sleeve gastrectomy (SG) on gastroesophageal reflux disease (GERD) is still greatly debated. Most of the current evidence available is solely based on symptom evaluation or medication use, while a minority have implemented objective functional measurements. LONG VERSUS SHORT BILIOPANCREATIC LIMB IN ROUX-EN-Y The Roux-en-Y gastric bypass continues to be one of the most performed bariatric surgeries because of its adequate balance of outcomes, complications, and durability. Recently, the role of the biliopancreatic limb on weight loss and co-morbidity control has gained attention because it seems to have a positive impact based onlimb length.
MESENTERIC VISCERAL LIPECTOMY USING TISSUE LIQUEFACTION Visceral obesity is associated with diabetogenic and atherogenic abnormalities, including insulin resistance and increased risk for cardiometabolic diseases and mortality. Rodent lipectomy studies have demonstrated a causal link between visceral fat and insulin resistance, yet human omentectomy studies have failed to replicate this metabolic benefit, perhaps owing to the inability to THE EFFECT OF OMENTECTOMY ADDED TO BARIATRIC SURGERY ON Obesity is a growing worldwide epidemic, having tripled in prevalence since 1975 and estimated to be affecting >650 million adults in 2016 . The disease is closely associated with diabetes, coronary heart disease, and sleep apnea . Bariatric surgery results in greater weight loss compared with nonsurgical treatment and can lead to the improvement or resolution of type 2 diabetes (T2D) . STATE LAWS ON INSURANCE COVERAGE FOR BARIATRIC SURGERY Several states have enacted similar legislature with regard to bariatric surgery coverage. This study originally was designed to survey the Department of Insurance in each state in the United States as to whether that state had legislation regarding bariatric surgery insurance coverage and its effect on insurance premiums, claims, andpayouts.
ABNORMAL GLUCOSE TOLERANCE TESTING AFTER GASTRIC BYPASS the 1-way analysis of variance test, it was determined that no significant difference was present between the groups with respect to weight regain (P.631) or the %EBL (P.161; Table 4). MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE AND HIATAL Surgery for Obesity and Related Diseases 13 (2017) 2032–2036 Surgeon-at-work Management of gastroesophageal reflux disease andhiatal hernia
HEALTH IS A STATE OF COMPLETE PHYSICAL, MENTAL AND SOCIAL11 Health is a state of complete physical, mental, and social well-being and not merely the absence of disease or infirmity . As stated by the World Health Organization in 1948, health describes more than the mere integrity of the physical body. It depicts the wholesomeness of a human being understood as a composition of bodily, emotional, intellectual, and social as well as material parts, in THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AFTER The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is discouraged after bariatric surgery. The effect of NSAIDs on patients who have undergone sleeve gastrectomy (SG) is not well studied. Moreover, the rate of NSAID use after SG is unknown. A NOVEL RISK PREDICTION MODEL FOR 30-DAY SEVERE ADVERSE12 As evidenced by previous studies, bariatric surgery is the most effective and long-lasting treatment for morbid obesity. The 2 most commonly performed bariatric procedures in the U.S. are laparoscopic Roux-en-Y gastric bypass (23.1% based on 2015 American Society of Metabolic and Bariatric Surgeon estimates) and laparoscopic sleeve gastrectomy (53.8%). LAPAROSCOPIC MANAGEMENT OF REFLUX AFTER ROUX-EN-Y GASTRIC Roux-en-Y gastric bypass (RYGB) has been advocated for the treatment of gastroesophageal reflux in obese and nonobese patients . Its effect in the resolution of reflux symptoms has been shown to be independent of weight loss . The mechanism of its action in controlling reflux is reducing parietal cells in the stomach pouch as well as diverting bile via the COMPARISON OF ENDOSTAPLER PERFORMANCE IN CHALLENGING test and a Kruskal-Wallis ranked median test with a ¼ .05 to compare the medians were conducted. H 0: The population medians are all equal. H 1: The medians are not all equal. Malformed staples evaluation. Thenumber of malformed
LAPAROSCOPIC DISTALIZATION OF GASTRIC BYPASS Background: The patient is a 37 year-old female with a history of super morbid obesity who had previously undergone a laparoscopic roux-en-Y gastric bypass 5 years ago with a 120cm roux limb. She initially experienced satisfactory weight loss, however subsequently had significant weight re-gain despite compliance with dietary advice and continued exercise. DEHYDRATION: A CAUSE FOR CONCERN Dehydration occurs when the body loses too much fluid. Signs and symptoms of dehydration include: thirst, decrease in skin turgor, dry or cool skin, dry mucous membranes, constipation, low or minimal urine output, muscle cramps, tachycardia, hypotension, light headedness, feeling dizzy, headache, fever , nausea, malaise, diaphoresis HEALTH DISPARITY IN ACCESS TO BARIATRIC SURGERY treatment and, therefore, subsequent worse postoperative outcomes, including longer hospital lengths of stay and increased mortality . Sociodemographicdisparities intermsofaccesstobariat- 15+ YEAR WEIGHT CHANGE OUTCOMES AND COMPLICATIONS AFTER Roux-en-Y gastric bypass (RYGB) is the most commonly performed bariatric surgery procedure in the United States. The short-term outcomes following RYGB have been well studied; however, evidence on long-term (≥5 years) outcomes following RYGB is sparse, particularly in the U.S. population. Using data from patients who underwent RYGB at Washington University School of Medicine in St. Louis, we A287 EFFECT OF GASTRIC BYPASS AND VERY-LOW ENERGY DIET ON Seventy-eight subjects (52 women), mean (SD) age 48 (10) years, weight 128 (24) kg, BMI 43 (6) kg/m 2, underwent GBP (n=40) or VLED (n=38).Mean 9-week weight-losses were 16.7 (3.6) and 13.9 (4.6) kg, respectively, P=0.005.Fat-mass was reduced by 12 (3.4) and 10.8 (3.5) kg, P=0.15, and fat-free mass by 4.7 (3.2) and 3.1 (2.2) kg (P=0.018).Baseline-values of CMRF did not differ significantly HEALTH IS A STATE OF COMPLETE PHYSICAL, MENTAL AND SOCIAL11 Health is a state of complete physical, mental, and social well-being and not merely the absence of disease or infirmity . As stated by the World Health Organization in 1948, health describes more than the mere integrity of the physical body. It depicts the wholesomeness of a human being understood as a composition of bodily, emotional, intellectual, and social as well as material parts, in THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AFTER The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is discouraged after bariatric surgery. The effect of NSAIDs on patients who have undergone sleeve gastrectomy (SG) is not well studied. Moreover, the rate of NSAID use after SG is unknown. A NOVEL RISK PREDICTION MODEL FOR 30-DAY SEVERE ADVERSE12 As evidenced by previous studies, bariatric surgery is the most effective and long-lasting treatment for morbid obesity. The 2 most commonly performed bariatric procedures in the U.S. are laparoscopic Roux-en-Y gastric bypass (23.1% based on 2015 American Society of Metabolic and Bariatric Surgeon estimates) and laparoscopic sleeve gastrectomy (53.8%). LAPAROSCOPIC MANAGEMENT OF REFLUX AFTER ROUX-EN-Y GASTRIC Roux-en-Y gastric bypass (RYGB) has been advocated for the treatment of gastroesophageal reflux in obese and nonobese patients . Its effect in the resolution of reflux symptoms has been shown to be independent of weight loss . The mechanism of its action in controlling reflux is reducing parietal cells in the stomach pouch as well as diverting bile via the COMPARISON OF ENDOSTAPLER PERFORMANCE IN CHALLENGING test and a Kruskal-Wallis ranked median test with a ¼ .05 to compare the medians were conducted. H 0: The population medians are all equal. H 1: The medians are not all equal. Malformed staples evaluation. Thenumber of malformed
LAPAROSCOPIC DISTALIZATION OF GASTRIC BYPASS Background: The patient is a 37 year-old female with a history of super morbid obesity who had previously undergone a laparoscopic roux-en-Y gastric bypass 5 years ago with a 120cm roux limb. She initially experienced satisfactory weight loss, however subsequently had significant weight re-gain despite compliance with dietary advice and continued exercise. DEHYDRATION: A CAUSE FOR CONCERN Dehydration occurs when the body loses too much fluid. Signs and symptoms of dehydration include: thirst, decrease in skin turgor, dry or cool skin, dry mucous membranes, constipation, low or minimal urine output, muscle cramps, tachycardia, hypotension, light headedness, feeling dizzy, headache, fever , nausea, malaise, diaphoresis HEALTH DISPARITY IN ACCESS TO BARIATRIC SURGERY treatment and, therefore, subsequent worse postoperative outcomes, including longer hospital lengths of stay and increased mortality . Sociodemographicdisparities intermsofaccesstobariat- 15+ YEAR WEIGHT CHANGE OUTCOMES AND COMPLICATIONS AFTER Roux-en-Y gastric bypass (RYGB) is the most commonly performed bariatric surgery procedure in the United States. The short-term outcomes following RYGB have been well studied; however, evidence on long-term (≥5 years) outcomes following RYGB is sparse, particularly in the U.S. population. Using data from patients who underwent RYGB at Washington University School of Medicine in St. Louis, we A287 EFFECT OF GASTRIC BYPASS AND VERY-LOW ENERGY DIET ON Seventy-eight subjects (52 women), mean (SD) age 48 (10) years, weight 128 (24) kg, BMI 43 (6) kg/m 2, underwent GBP (n=40) or VLED (n=38).Mean 9-week weight-losses were 16.7 (3.6) and 13.9 (4.6) kg, respectively, P=0.005.Fat-mass was reduced by 12 (3.4) and 10.8 (3.5) kg, P=0.15, and fat-free mass by 4.7 (3.2) and 3.1 (2.2) kg (P=0.018).Baseline-values of CMRF did not differ significantly GUIDELINES FOR GASTROSTOMY TUBE PLACEMENT AND ENTERAL Postbariatric hypoglycemia (PBH) affects up to 38% of Roux-en-Y gastric bypass (RYGB) patients. Severe cases are refractory to diet and medications. Surgical treatments including bypass reversal and pancreatectomy are highly morbid and hypoglycemia often recurs. We have developed a highly effective method of treatment by which enteral nutrition administered through a gastrostomy (G) tube A NOVEL RISK PREDICTION MODEL FOR 30-DAY SEVERE ADVERSE As evidenced by previous studies, bariatric surgery is the most effective and long-lasting treatment for morbid obesity. The 2 most commonly performed bariatric procedures in the U.S. are laparoscopic Roux-en-Y gastric bypass (23.1% based on 2015 American Society of Metabolic and Bariatric Surgeon estimates) and laparoscopic sleeve gastrectomy (53.8%). SLEEVE GASTRECTOMY AND GASTROESOPHAGEAL REFLUX: A The impact of sleeve gastrectomy (SG) on gastroesophageal reflux disease (GERD) is still greatly debated. Most of the current evidence available is solely based on symptom evaluation or medication use, while a minority have implemented objective functional measurements. A287 EFFECT OF GASTRIC BYPASS AND VERY-LOW ENERGY DIET ON Seventy-eight subjects (52 women), mean (SD) age 48 (10) years, weight 128 (24) kg, BMI 43 (6) kg/m 2, underwent GBP (n=40) or VLED (n=38).Mean 9-week weight-losses were 16.7 (3.6) and 13.9 (4.6) kg, respectively, P=0.005.Fat-mass was reduced by 12 (3.4) and 10.8 (3.5) kg, P=0.15, and fat-free mass by 4.7 (3.2) and 3.1 (2.2) kg (P=0.018).Baseline-values of CMRF did not differ significantly LONG VERSUS SHORT BILIOPANCREATIC LIMB IN ROUX-EN-Y The Roux-en-Y gastric bypass continues to be one of the most performed bariatric surgeries because of its adequate balance of outcomes, complications, and durability. Recently, the role of the biliopancreatic limb on weight loss and co-morbidity control has gained attention because it seems to have a positive impact based onlimb length.
BARIATRIC SURGERY IN PATIENTS WITH LIVER CIRRHOSIS Data regarding the management of bariatric patients with cirrhosis are scarce, and there is no strong evidence that supports a specific approach for this group of patients. The aim of this study was to review our experience with cirrhotic patients undergoing bariatricsurgery.
THE POSTOPERATIVE CHECKLIST FOR BARIATRIC SURGERY Morbidly obese patients are at higher risk of intra-operative and short- and long term complications after surgery. In bariatric surgery pre- and intra-operative checklists are commonly used as a safety tool to standardize care and to identify high risk patients preoperatively, in order to decrease the number of postoperative complications. However, in current literature information on the use “CANDY CANE SYNDROME:” AN UNDERAPPRECIATED CAUSE OF “Candy cane” syndrome (a blind afferent Roux limb at the gastrojejunostomy) has been implicated as a cause of abdominal pain, nausea, and emesis after Roux-n-Y gastric bypass (RYGB) but remainspoorly described.
BILIARY RECONSTRUCTION OPTIONS FOR BILE DUCT STRICTURE IN Surgery for Obesity and Related Diseases 13 (2017) 1629–1634 Surgeon-at-work Biliary reconstruction options for bile duct stricturein patients
BARIATRIC SURGERY PATIENTS WITH FIBROMYALGIA Fibromyalgia (FM) prevalence is higher in patients with obesity (27- 45%) compared to the general US adult population (2%). Patients with obesity and FM historically report more medical comorbidities, higher disability, increased depressive symptoms, less activity, and greater medication usage. Less is known about patients with FM seeking bariatric surgery, particularly pre-operative HEALTH IS A STATE OF COMPLETE PHYSICAL, MENTAL AND SOCIAL11 Health is a state of complete physical, mental, and social well-being and not merely the absence of disease or infirmity . As stated by the World Health Organization in 1948, health describes more than the mere integrity of the physical body. It depicts the wholesomeness of a human being understood as a composition of bodily, emotional, intellectual, and social as well as material parts, in THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AFTER The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is discouraged after bariatric surgery. The effect of NSAIDs on patients who have undergone sleeve gastrectomy (SG) is not well studied. Moreover, the rate of NSAID use after SG is unknown. A NOVEL RISK PREDICTION MODEL FOR 30-DAY SEVERE ADVERSE12 As evidenced by previous studies, bariatric surgery is the most effective and long-lasting treatment for morbid obesity. The 2 most commonly performed bariatric procedures in the U.S. are laparoscopic Roux-en-Y gastric bypass (23.1% based on 2015 American Society of Metabolic and Bariatric Surgeon estimates) and laparoscopic sleeve gastrectomy (53.8%). LAPAROSCOPIC MANAGEMENT OF REFLUX AFTER ROUX-EN-Y GASTRICGASTRIC ROUX EN Y ANATOMYROUX AND Y PROCEDUREROUX EN Y BYPASS REVISIONROUX EN Y GASTRIC BYPASSJOURNAL OF GASTROINTESTINAL ENDOSCOPYROUX EN Y GASTRICBYPASS SURGERY
Roux-en-Y gastric bypass (RYGB) has been advocated for the treatment of gastroesophageal reflux in obese and nonobese patients . Its effect in the resolution of reflux symptoms has been shown to be independent of weight loss . The mechanism of its action in controlling reflux is reducing parietal cells in the stomach pouch as well as diverting bile via the COMPARISON OF ENDOSTAPLER PERFORMANCE IN CHALLENGING test and a Kruskal-Wallis ranked median test with a ¼ .05 to compare the medians were conducted. H 0: The population medians are all equal. H 1: The medians are not all equal. Malformed staples evaluation. Thenumber of malformed
LAPAROSCOPIC DISTALIZATION OF GASTRIC BYPASS Background: The patient is a 37 year-old female with a history of super morbid obesity who had previously undergone a laparoscopic roux-en-Y gastric bypass 5 years ago with a 120cm roux limb. She initially experienced satisfactory weight loss, however subsequently had significant weight re-gain despite compliance with dietary advice and continued exercise. DEHYDRATION: A CAUSE FOR CONCERN Dehydration occurs when the body loses too much fluid. Signs and symptoms of dehydration include: thirst, decrease in skin turgor, dry or cool skin, dry mucous membranes, constipation, low or minimal urine output, muscle cramps, tachycardia, hypotension, light headedness, feeling dizzy, headache, fever , nausea, malaise, diaphoresis HEALTH DISPARITY IN ACCESS TO BARIATRIC SURGERY treatment and, therefore, subsequent worse postoperative outcomes, including longer hospital lengths of stay and increased mortality . Sociodemographicdisparities intermsofaccesstobariat- 15+ YEAR WEIGHT CHANGE OUTCOMES AND COMPLICATIONS AFTER Roux-en-Y gastric bypass (RYGB) is the most commonly performed bariatric surgery procedure in the United States. The short-term outcomes following RYGB have been well studied; however, evidence on long-term (≥5 years) outcomes following RYGB is sparse, particularly in the U.S. population. Using data from patients who underwent RYGB at Washington University School of Medicine in St. Louis, we A287 EFFECT OF GASTRIC BYPASS AND VERY-LOW ENERGY DIET ON Seventy-eight subjects (52 women), mean (SD) age 48 (10) years, weight 128 (24) kg, BMI 43 (6) kg/m 2, underwent GBP (n=40) or VLED (n=38).Mean 9-week weight-losses were 16.7 (3.6) and 13.9 (4.6) kg, respectively, P=0.005.Fat-mass was reduced by 12 (3.4) and 10.8 (3.5) kg, P=0.15, and fat-free mass by 4.7 (3.2) and 3.1 (2.2) kg (P=0.018).Baseline-values of CMRF did not differ significantly HEALTH IS A STATE OF COMPLETE PHYSICAL, MENTAL AND SOCIAL11 Health is a state of complete physical, mental, and social well-being and not merely the absence of disease or infirmity . As stated by the World Health Organization in 1948, health describes more than the mere integrity of the physical body. It depicts the wholesomeness of a human being understood as a composition of bodily, emotional, intellectual, and social as well as material parts, in THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AFTER The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is discouraged after bariatric surgery. The effect of NSAIDs on patients who have undergone sleeve gastrectomy (SG) is not well studied. Moreover, the rate of NSAID use after SG is unknown. A NOVEL RISK PREDICTION MODEL FOR 30-DAY SEVERE ADVERSE12 As evidenced by previous studies, bariatric surgery is the most effective and long-lasting treatment for morbid obesity. The 2 most commonly performed bariatric procedures in the U.S. are laparoscopic Roux-en-Y gastric bypass (23.1% based on 2015 American Society of Metabolic and Bariatric Surgeon estimates) and laparoscopic sleeve gastrectomy (53.8%). LAPAROSCOPIC MANAGEMENT OF REFLUX AFTER ROUX-EN-Y GASTRICGASTRIC ROUX EN Y ANATOMYROUX AND Y PROCEDUREROUX EN Y BYPASS REVISIONROUX EN Y GASTRIC BYPASSJOURNAL OF GASTROINTESTINAL ENDOSCOPYROUX EN Y GASTRICBYPASS SURGERY
Roux-en-Y gastric bypass (RYGB) has been advocated for the treatment of gastroesophageal reflux in obese and nonobese patients . Its effect in the resolution of reflux symptoms has been shown to be independent of weight loss . The mechanism of its action in controlling reflux is reducing parietal cells in the stomach pouch as well as diverting bile via the COMPARISON OF ENDOSTAPLER PERFORMANCE IN CHALLENGING test and a Kruskal-Wallis ranked median test with a ¼ .05 to compare the medians were conducted. H 0: The population medians are all equal. H 1: The medians are not all equal. Malformed staples evaluation. Thenumber of malformed
LAPAROSCOPIC DISTALIZATION OF GASTRIC BYPASS Background: The patient is a 37 year-old female with a history of super morbid obesity who had previously undergone a laparoscopic roux-en-Y gastric bypass 5 years ago with a 120cm roux limb. She initially experienced satisfactory weight loss, however subsequently had significant weight re-gain despite compliance with dietary advice and continued exercise. DEHYDRATION: A CAUSE FOR CONCERN Dehydration occurs when the body loses too much fluid. Signs and symptoms of dehydration include: thirst, decrease in skin turgor, dry or cool skin, dry mucous membranes, constipation, low or minimal urine output, muscle cramps, tachycardia, hypotension, light headedness, feeling dizzy, headache, fever , nausea, malaise, diaphoresis HEALTH DISPARITY IN ACCESS TO BARIATRIC SURGERY treatment and, therefore, subsequent worse postoperative outcomes, including longer hospital lengths of stay and increased mortality . Sociodemographicdisparities intermsofaccesstobariat- 15+ YEAR WEIGHT CHANGE OUTCOMES AND COMPLICATIONS AFTER Roux-en-Y gastric bypass (RYGB) is the most commonly performed bariatric surgery procedure in the United States. The short-term outcomes following RYGB have been well studied; however, evidence on long-term (≥5 years) outcomes following RYGB is sparse, particularly in the U.S. population. Using data from patients who underwent RYGB at Washington University School of Medicine in St. Louis, we A287 EFFECT OF GASTRIC BYPASS AND VERY-LOW ENERGY DIET ON Seventy-eight subjects (52 women), mean (SD) age 48 (10) years, weight 128 (24) kg, BMI 43 (6) kg/m 2, underwent GBP (n=40) or VLED (n=38).Mean 9-week weight-losses were 16.7 (3.6) and 13.9 (4.6) kg, respectively, P=0.005.Fat-mass was reduced by 12 (3.4) and 10.8 (3.5) kg, P=0.15, and fat-free mass by 4.7 (3.2) and 3.1 (2.2) kg (P=0.018).Baseline-values of CMRF did not differ significantly GUIDELINES FOR GASTROSTOMY TUBE PLACEMENT AND ENTERAL Postbariatric hypoglycemia (PBH) affects up to 38% of Roux-en-Y gastric bypass (RYGB) patients. Severe cases are refractory to diet and medications. Surgical treatments including bypass reversal and pancreatectomy are highly morbid and hypoglycemia often recurs. We have developed a highly effective method of treatment by which enteral nutrition administered through a gastrostomy (G) tube A NOVEL RISK PREDICTION MODEL FOR 30-DAY SEVERE ADVERSE As evidenced by previous studies, bariatric surgery is the most effective and long-lasting treatment for morbid obesity. The 2 most commonly performed bariatric procedures in the U.S. are laparoscopic Roux-en-Y gastric bypass (23.1% based on 2015 American Society of Metabolic and Bariatric Surgeon estimates) and laparoscopic sleeve gastrectomy (53.8%). SLEEVE GASTRECTOMY AND GASTROESOPHAGEAL REFLUX: A The impact of sleeve gastrectomy (SG) on gastroesophageal reflux disease (GERD) is still greatly debated. Most of the current evidence available is solely based on symptom evaluation or medication use, while a minority have implemented objective functional measurements. A287 EFFECT OF GASTRIC BYPASS AND VERY-LOW ENERGY DIET ON Seventy-eight subjects (52 women), mean (SD) age 48 (10) years, weight 128 (24) kg, BMI 43 (6) kg/m 2, underwent GBP (n=40) or VLED (n=38).Mean 9-week weight-losses were 16.7 (3.6) and 13.9 (4.6) kg, respectively, P=0.005.Fat-mass was reduced by 12 (3.4) and 10.8 (3.5) kg, P=0.15, and fat-free mass by 4.7 (3.2) and 3.1 (2.2) kg (P=0.018).Baseline-values of CMRF did not differ significantly LONG VERSUS SHORT BILIOPANCREATIC LIMB IN ROUX-EN-Y The Roux-en-Y gastric bypass continues to be one of the most performed bariatric surgeries because of its adequate balance of outcomes, complications, and durability. Recently, the role of the biliopancreatic limb on weight loss and co-morbidity control has gained attention because it seems to have a positive impact based onlimb length.
BARIATRIC SURGERY IN PATIENTS WITH LIVER CIRRHOSIS Data regarding the management of bariatric patients with cirrhosis are scarce, and there is no strong evidence that supports a specific approach for this group of patients. The aim of this study was to review our experience with cirrhotic patients undergoing bariatricsurgery.
THE POSTOPERATIVE CHECKLIST FOR BARIATRIC SURGERY Morbidly obese patients are at higher risk of intra-operative and short- and long term complications after surgery. In bariatric surgery pre- and intra-operative checklists are commonly used as a safety tool to standardize care and to identify high risk patients preoperatively, in order to decrease the number of postoperative complications. However, in current literature information on the use “CANDY CANE SYNDROME:” AN UNDERAPPRECIATED CAUSE OF “Candy cane” syndrome (a blind afferent Roux limb at the gastrojejunostomy) has been implicated as a cause of abdominal pain, nausea, and emesis after Roux-n-Y gastric bypass (RYGB) but remainspoorly described.
BILIARY RECONSTRUCTION OPTIONS FOR BILE DUCT STRICTURE IN Surgery for Obesity and Related Diseases 13 (2017) 1629–1634 Surgeon-at-work Biliary reconstruction options for bile duct stricturein patients
BARIATRIC SURGERY PATIENTS WITH FIBROMYALGIA Fibromyalgia (FM) prevalence is higher in patients with obesity (27- 45%) compared to the general US adult population (2%). Patients with obesity and FM historically report more medical comorbidities, higher disability, increased depressive symptoms, less activity, and greater medication usage. Less is known about patients with FM seeking bariatric surgery, particularly pre-operative Skip to Main Content*
* RSS Feeds
* Login
* Register
Claim Subscription
* Subscribe
* Articles & Issues
* Articles In Press
* Current Issue
* List of Issues
* Multimedia
* Multimedia Library* Collections
* Volume Indices
* For Authors
* About Open Access
* Author Information * Conflicts of Interest* Permissions
* Researcher Academy * Submit a Manuscript* For Reviewers
* CME Reviewer Scoresheet * Reviewer Guidelines* Journal Info
* About Open Access
* About the Journal
* Abstracting/Indexing * Activate Online Access * Career Opportunities * Contact Information* Editorial Board
* Info for Advertisers * Mobile Access Instructions* Pricing
* Related Sites
* Reprints
* New Content Alerts* Subscribe
* Society Information* ASMBS
* SBCBM
* More Periodicals
* Find a Periodical
* Go to Product Catalog Search Terms Search within All Content Article Title, Abstract, Keywords Authors Article Title Abstract Search Advanced SearchSHARE THIS PAGE:
* Mendeley
AddThis
ISSUE HIGHLIGHTS
BANDED VERSUS NONBANDED LAPAROSCOPIC SLEEVE GASTRECTOMY: 5-YEAROUTCOMES
VALIDATION OF BIOCHEMICAL SCORES FOR LIVER STEATOSIS BEFORE AND 1 YEAR AFTER SLEEVE GASTRECTOMY IMPROVEMENTS IN HUMORAL IMMUNE FUNCTION AND GLUCOLIPID METABOLISM AFTER LAPAROSCOPIC SLEEVE GASTRECTOMY IN PATIENTS WITH OBESITY Previous slide Pause slideNext slide
* show Slide 11
* show Slide 22
* show Slide 33
*
ARTICLES IN PRESS
*
Most Read
*
Most Cited
*
From the Editor
*
Weight loss and Effect on Comorbidities in the Long Term after Duodenal Switch and Gastric Bypass: A population-based cohort study Martin L. Skogar, Magnus Sundbom DOI: https://doi.org/10.1016/j.soard.2019.09.077 Publication stage: In Press Accepted Manuscript PreviewFull-Text HTML PDF xUnsatisfactory weight loss is common after bariatric surgery in patients with super obesity (Body Mass Index ≥50 kg/m2). Unfortunately, this group of patients is increasing worldwide.*
Systematic Review of Perioperative Use of Immunosuppressive Agents in Patients Undergoing Bariatric Surgery Lynn Kassel, Anastasia Hutton, Gregory Zumach, Joel Rand DOI: https://doi.org/10.1016/j.soard.2019.10.002 Publication stage: In Press Accepted Manuscript PreviewFull-Text HTML PDF xPatients who qualify for bariatric surgery are increasingly experiencing comorbid conditions which often require management through the use of immunosuppressive agents, such as corticosteroids, tumor necrosis alpha factor inhibitors, or other immunomodulators, which may increase risk of infection or wound healing complications. Perioperative management of these agents in bariatric surgery is challenging due to lack of research in that patient population. With immunosuppressive agents use on the rise, the effects of these medications must be understood, the risks posed in the perioperative period, and the benefit their sustained use may have for comorbiditymanagement.
*
Laparoscopic sleeve gastrectomy induces sustained changes in gray and white matter brain volumes and resting functional connectivity inobese patients
Yuanyuan Wang, Gang Ji, Yang Hu, Guanya Li, Yueyan Ding, Chunxin Hu, Lei Liu, Wenchao Zhang, Karen M. von Deneen, Yu Han, Guangbin Cui, Huaning Wang, Peter Manza, Nora D. Volkow, Yongzhan Nie, Gene-JackWang, Yi Zhang
DOI: https://doi.org/10.1016/j.soard.2019.09.074 Publication stage: In Press Accepted Manuscript PreviewFull-Text HTML PDF Supplemental Materials xObesity is associated with decreased brain gray- (GM)/white-matter (WM) volumes in regions. Laparoscopic-sleeve-gastrectomy (LSG) is an effective bariatric surgery associated with neuroplastic changes in patients with obesity at 1-month-post-LSG.*
Neuroimaging correlates of cognitive changes following bariatricsurgery
Amit M. Saindane, Daniel L. Drane, Arvinpal Singh, Junjie Wu, DeqiangQiu
DOI: https://doi.org/10.1016/j.soard.2019.09.076 Publication stage: In Press Accepted Manuscript PreviewFull-Text HTML PDF xObesity has been associated with cognitive deficits and increased risk for developing dementia. Bariatric surgery may result in improved cognitive function; however, the underlying structural and functional brain correlates are unclear.*
Effects of bariatric surgery on DNA methylation in adults: a systematic review and meta-analysis Khalil ElGendy, Fiona C. Malcomson, D. Michael Bradburn, John C.Mathers
DOI: https://doi.org/10.1016/j.soard.2019.09.075 Publication stage: In Press Accepted Manuscript PreviewFull-Text HTML PDF Supplemental Materials xDNA methylation is an epigenetic mechanism through which environmental factors, including obesity influence health. Obesity is a major modifiable risk factor for many common diseases including cardiovascular diseases and cancer. Obesity-induced metabolic stress and inflammation are key mechanisms that affect disease risk and which may result from changes in methylation of metabolic and inflammatorygenes.
View More Articles in Press*
Conception rates and contraceptive use after bariatric surgery among women with infertility: Evidence from a prospective multicentercohort study
Marie N. Menke, Wendy C. King, Gretchen E. White, Gabriella G. Gosman, Anita P. Courcoulas, Gregory F. Dakin, David R. Flum, Molly J. Orcutt, Alfons Pomp, Walter J. Pories, Jonathan Q. Purnell, Kristine J. Steffen, Bruce M. Wolfe, Susan Z. Yanovski DOI: https://doi.org/10.1016/j.soard.2018.12.026 Vol. 15, Issue 5, p777–785Full-Text HTML PDF
*
ASMBS Allied Health Nutritional Guidelines for the Surgical WeightLoss Patient
Allied Health Sciences Section Ad Hoc Nutrition Committee Linda Aills, Jeanne Blankenship, Cynthia Buffington, Margaret Furtado, JulieParrott
DOI: https://doi.org/10.1016/j.soard.2008.03.002 Vol. 4, Issue 5, S73–S108Full-Text HTML PDF
*
What could happen if you insert a BioEnterics intragastric balloon after sleeve gastrectomy? Hiba Hassan El Hage Chehade, Ziad Omar El khatib, Houssam Khodor Abtar DOI: https://doi.org/10.1016/j.soard.2015.05.015 Vol. 11, Issue 5, e39–e41Open AccessFull-Text HTML PDF
*
Unacylated ghrelin is correlated with the decline of bone mineral density after Roux-en-Y gastric bypass in obese Chinese with type 2diabetes
Jiajia Wang, Jingyuan Ma, Haoyong Yu, Pin Zhang, Junfeng Han, YuqianBao
DOI: https://doi.org/10.1016/j.soard.2019.04.011 Vol. 15, Issue 9, p1473–1480Open AccessFull-Text HTML PDF
*
Laparoscopic management of reflux after Roux-en-Y gastric bypass using the LINX system and repair of hiatal hernia: a casereport
Abdelkader Hawasli, Adam Phillips, Moayad Tarboush DOI: https://doi.org/10.1016/j.soard.2016.02.037 Vol. 12, Issue 5, e51–e54Open AccessFull-Text HTML PDF
MOST CITED SURGERY FOR OBESITY AND RELATED DISEASES * International sleeve gastrectomy expert panel consensus statement: Best practice guidelines based on experience of >12,000 cases(Cited 464 time(s))
2012; Rosenthal, R.J. * Systematic review of sleeve gastrectomy as staging and primarybariatric procedure
(Cited 331 time(s))
2009; Brethauer, S.A. | Hammel, J.P. | Schauer, P.R. * Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient - 2013 update: Cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery(Cited 302 time(s))
2013; Mechanick, J.I. | Youdim, A. | Jones, D.B. | Timothy Garvey, W.| Hurley, D.L. |...
* ASMBS Allied Health Nutritional Guidelines for the Surgical WeightLoss Patient
(Cited 274 time(s))
2008; Aills, L. | Blankenship, J. | Buffington, C. | Furtado, M. |Parrott, J.
* Consensus Conference Statement. Bariatric surgery for morbid obesity: Health implications for patients, health professionals, andthird-party payers
(Cited 252 time(s))
2005; Buchwald, H. | Owen, H. | Wangensteen, S.D. | Billington, C.J. |Detre, K.M. |...
* Access all results for your search in ScopusContent provided by
*
ABOUT _JOURNAL_
*
Society Information
_Surgery for Obesity and Related Diseases_ (SOARD), the Official Journal of the American Society for Metabolic and Bariatric Surgery (ASMBS) and the Brazilian Society for Bariatric Surgery , is an international journal devoted to the publication of peer-reviewed manuscripts of the highest quality with objective data regarding techniques for the treatment of severe obesity. Articles document the effects of surgically induced weight loss on obesity physiological, psychiatric and social co-morbidities. The Editorial Board includes internationally prominent individuals who are devoted to the optimal treatment of the severely obese and include internists, psychiatrists, surgeons, and nutritional experts. Manuscripts are blindly reviewed without the reviewers knowledge of the authors, institution or country of origin. The American Society for Metabolic and Bariatric Surgery (ASMBS) is the largest society for this specialty in the world. It was organized in 1983 as an association of bariatric surgeons which emerged from the earlier University of Iowa Colloquia on bariatric surgery founded and directed by Dr. Edward E. Mason who was also the society's first president. Brazilian Society for Bariatric and Metabolic Surgery (SBCBM)SOCIAL MEDIA
*
*
*
Journal Club
Tweets by asmbs
Coming soon...
VISUAL ABSTRACTS
CURRENT ISSUE
* September 2019
* Volume 15, Issue 9 Subscribe to JournalSeptember 2019
Volume 15, Issue 9
Receive Content AlertsFree Trial Issue
Access this journal on ScienceDirect Visit ScienceDirect to see if you have access via your institution.LIST OF ISSUES
Supports Open Access Learn more about open access options.
MOBILE APPS
Access instructions
REVIEWERS-HOW TO REVIEW FOR _SOARD_Please click here
for the guidelines on how to peer review a manuscript.JOURNAL METRICS
3.758
2018
Impact
Factor
2.7 weeks
For first
decision
91st percentile*
Medicine: Surgery
*Citescore
VIDEO CASE REPORTS
Single port–assisted laparoscopic sleeve gastrectomy: a new approach to the growth of reproducibility of the single portretain Copyright © 2019 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Use of Cookies | About Us| Help &
Contact | Accessibility The content on this site is intended for health professionals. We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.
Advertisements on this site do not constitute a guarantee or endorsement by the journal, Association, or publisher of the quality or value of such product or of the claims made for it by itsmanufacturer.
Loginclose
Email/Username:
Password:
Remember me
Forgot password?
Click to get updates and verify authenticity.Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0